Success Stories: Our Team of Experts Secured NIW Approval for A Chinese Associate Scientist in the Field of Biomedical Engineering in Only 2 Days
Client’s Testimonial:
“Thanks for the good news - it is crucial to mention that your help made this case successful.”
On September 20th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Scientist in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: Associate Scientist
Country of Origin: China
Approval Notice Date: September 20th, 2023
Processing Time: 2 days (Premium Processing During Filing)
Case Summary:
Our client, a biomedical engineering professional and a holder of a Ph.D. in chemical and biomolecular engineering, hired the North America Immigration Law Group to assist in helping him file a National Interest Waiver (NIW) petition. Our team noted his proposed endeavor was to continue his research on developing complex in vitro models focusing on therapeutic methods targeting soft tissue to study cancer- and infection-induced immune responses. In addition, biomedical engineering has been recognized by the USCIS as a critical and emerging technology. After our team completed inspecting his background, we agreed to take him as a client, and we included the following details in his personalized petition package:
- Our client has published 3 peer-reviewed journal articles (2 of them first-authored), with 2 of his papers being published in top journals in our client’s field.
- His work has been cited a total of 26 times at the time of the petition, demonstrating that his publications are widely recognized and relied upon in the field of biomedical engineering.
- His proposed endeavor also has broad implications for the United States. His work is vital for addressing significant national health concerns, as leukemia has been the 6th most common cause of cancer death for women, and his research has addressed the assessment of kinase inhibitors and their side effects, highlighting the associated bleeding risk increase due to an inhibition of platelet deposition on collagen, reducing this associated risk is significant for improving patient healthcare outcomes.
- Based on the clear importance of his research, it has been supported with funding from the National Institutes of Health (NIH).
- Lastly, our client has also received letters of recommendation from 4 different experts, with one saying:
“I want to emphasize the significance of {Client}’s studies. The global drug development industry relies on scientific discoveries such as this to confirm the role of new proteins before they commence trials on them. His studies uncover new findings to guide the drug development process and also provide critical models and experimental methods to use in doing so.”
Given the information listed above, we were able to construct a winning case and secure approval for his petition in a mere 2 days. We wish our client continued success in his future endeavors and are grateful for his faith in our firm.